Amino Acid Metabolism Flashcards
Amino group (NH2) of aa metabolism
Liver–>urea all other tissues–>glutamate–(+NH2)–>glutamine
Carbon skeleton of aa metabolism 3 ways
- glucogenic aa–> glucose synthesis 2. ketogenic aa–>ketone bodies: β hydroxy butyrate acetoacetate acetone (gas) 3. energy least of the three
digestion of dietary proteins
- pepsin released by chief cells of the stomach 2a. apical membrane bound peptidases released by small intestine 2b. exocrine pancreatic enzymes trypsin chymotrypsin aminopeptidases elastases –>small peptides (80%) and free aa (20%) in the intestinal lumen
peptide absorption in enterocytes
small peptides are transported through the PEPT1 active transporter–peptidases in enterocyte–>aa–>transported into the blood using aa transporters
PEPT1 is a cotransporter of small peptides and protons into the enterocyte
free aa absorption in enterocytes
free aa enter are transported into the enterocyte using aa transporters
PEPT1 transport driving force
active force driven by electrochemical proton gradient more protons in the lumen/ less in the enterocyte. more acidic lumen pH at the center of the lumen 7.0-7.4 pH near apical border of enterocyte 5.5-6.0
Disease: Hartnup’s Disease
- genetic defect in the neutral aa transporters in intestine (apical membrane) and kidney (apical membrane)
- results/symptoms: cystinuria, pellagra-like symptoms (b/c Trp–>niacin), neutral aa in the urine, neurological problems
- test: give tryptophan orally; no free trp can enter enter intestinal cells;
- tryptophan also can’t enter kidney–>excreted in urine
- treatment: give tryptophan in the form of a small peptide: Gly-Trp, Trp-Trp, Lys-Trp; these enter through PEPT1
- benign in this country
- applies to all neutral aa:
Disease: Cystinuria
- genetic defect in basic aa (Lys, Arg) and cystine transporters in the intestine and kidney
- no malabsorption b/c these aa can be digested as peptides such as Lys-Leu
-
results/symptoms: Lys, Arg, and Cystine in the urine
- excess cystine in kidney(crystallization–>kidney stones
- treatment: drink 8-10 glasses of water a day or drink more beer (increases water reabsorption)
Marasmus Disease
- Protein and energy (carbohydrates and fats) deficiency in diet–starvation
- results/symptoms: stunted growth, loss of adipose tissue, muscle wasting, generalized wasting of protein mass, and NO EDEMA
- low plasma insulin, high plasma glucagon, high plasma glucocorticoids (cortisol)–>increased gluconeogenesis from glycerol (increased lipolysis) and glucogenic aa (increased muscle protein breakdown) to maintain blood glucose levels to support the brain.
- increased fatty acid mobilization from adipose tissue to liver–> increased production of ketone bodies–
- ketone bodies can serve as substrates for energy production in the brain
Kwashiorkor Disease
- Protein deficiency in diet; energy intake (carbohydrates and fat) adequate
- child eats more carbs to compensate for protein deficiency
- High plasma insulin, low plasma glucagon, low plasma gluccorticoid (cortisol)–>Lipolysis in adipose tissue is inhibited, fatty acid synthesis in liver is enhanced (fatty liver), mobilization of aa from muscle is inhibited
- Decreased levels of aa in the blood–>decreased protein synthesis in liver–>hypoalbuminemia–>edema (water accumulation in extracellular fluid in tissues)
- results/symptoms: growth failure, edema, hypoalbuminemia, and fatty liver
- eats more carbs–>excess glucose–>fats–>deposited in liver (abdominal protrusion and shiny skin)
Kwashiokor Disease and Marasmus Disease
table
AA carbon skeleton metabolism
Glucogenic aa can be converted into:
- pyruvate
- alpha Ketoglutarate
- Succinyl CoA
- Fumarate
- Oxaloacetate
Glucogenic aa converted to pyruvate
- Glycine
- Alanine
- Serine
- Cysteine
- Threonine
- Tryptophan
Glucogenic aa converted to alpha Ketoglutarate
- Glutamate
- Glutamine
- Histidine
- Arginine
- Proline
Glucogenic aa converted to Succinyl CoA
- Isoleucine
- Methionine
- Threonine
- Valine
Glucogenic aa converted to Fumarate
- Phenylalanine
- Tyrosine
- Aspartate